TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
Read moreTRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
Read more(Sharecast News) - Cell-based therapy developer MaxCyte announced the signing of a strategic platform licence with clinical-stage biotechnology company Celularity on Tuesday.
Read moreIN BRIEF: MaxCyte prepares for listing in New York
Read more(Sharecast News) - Cell engineering technology company MaxCyte has submitted a draft registration statement with the Securities and Exchange Commission (SEC), it announced on Friday, for a proposed dual-listing and public offering of shares on the Nasdaq market.
Read moreIN BRIEF: MaxCyte to consolidate two lines of common stock into one
Read more(Sharecast News) - Cell engineering company MaxCyte announced the consolidation of two of its lines of common stock into a single unrestricted line of common stock on Thursday.
Read moreTRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss
Read more(Sharecast News) - Cell engineering technology company MaxCyte reported a 21% year-on-year improvement in revenues in its final results on Tuesday, to $26.2m (£18.74m), despite the challenges of the Covid-19 pandemic.
Read more(Sharecast News) - Cell engineering and life sciences company MaxCyte has announced a subscription to raise £40m, in a bid to strengthen its balance sheet.
Read moreIN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing
Read moreLONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%
Read moreUK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020
Read moreMaxcyte Core Life Sciences Business Results To Beat Expectations
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO
Read more